1 hr
Biotalk Episode 11: A Conversation with Shehnaaz Suliman of ReCode Therapeutics Biotalk
-
- Life Sciences
On this episode of Biotalk, Locust Walk‘s Daniel Brog welcomes with Shehnaaz Suliman, M.D., CEO of ReCode Therapeutics, a clinical-stage genetic medicines company using its selective organ targeting lipid nanoparticle platform to power the next wave of mRNA and gene correction therapeutics. With over 25 years of experience, Shehnaaz brings a multifaceted perspective to the discussion. She […]
On this episode of Biotalk, Locust Walk‘s Daniel Brog welcomes with Shehnaaz Suliman, M.D., CEO of ReCode Therapeutics, a clinical-stage genetic medicines company using its selective organ targeting lipid nanoparticle platform to power the next wave of mRNA and gene correction therapeutics. With over 25 years of experience, Shehnaaz brings a multifaceted perspective to the discussion. She […]
1 hr